ICH Q6B provides expectations and a clear framework for the structural characterization of biopharmaceutical products.

Global Peptide Drug Conjugate Market USD 1400 Million Opportunity Says Kuick Research In New Study. Delhi, June 05, 2025 ...

The latest edition of "Column Watch" features our annual review of new liquid chromatography columns and accessories, ...

Mounjaro (tirzepatide), a weight-loss injection, is now approved to treat moderate-to-severe obstructive sleep apnea in obese ...

This study presents compelling evidence that the denitrosylase SCoR2 regulates cardioprotective metabolic reprogramming in the heart following ischemia/reperfusion injury. The findings are supported ...

In May 2025, Eli Lilly and Company conducted a study is to evaluate the safety and efficacy of LY3541860 in adult participants with multiple sclerosis that gets worse and gets better. The study will ...

A research group in Korea has discovered a novel natural antimicrobial peptide, "Hirunipin-2," from the salivary glands of ...

Funding expected to support operations into Q1 2026. Anticipated AMPLIFY-7P Phase 2 interim analysis expected in Q3 2025. BOSTON, Ju ...

Constructive Bio in Cambridge now holds the exclusive licence to ‘tRNA Display’ technology from the MRC Laboratory of ...

Researchers design a nanovaccine that detects MRSA toxins, kills bacteria with heat, and captures antigens to train the ...